References
- Richardson J A, Herron G, Reitz R. Ischemic ulcerations and necrosis of muscle in azotemic hyperparathyroidism. Ann Intern Med 1969; 71: 129–133
- Conn J, Jr, Krumlovsky F A, DelGreco F, Simon N M. Calciphylaxis etiology of progressive vascular calcification and gangrene. Ann Surg 1973; 177: 206–210
- Khafif R A, Delima C, Silverberg A, Frakel R. Calciphylaxis and systemic calcinosis. Arch Intern Med 1990; 150: 956–959
- El-Reshaid K, Johny K V, Sugathan T N, Hakim A, Georgous M, Nampoory M RN. End-stage renal disease and renal replacement therapy in Kuwait: epidemiological profile over the past four and half years. Nephrol Dial Transplant 1994, (in press)
- Meema H E, Oreopoulos D G. The incidence, progression and regression of arterial calcification in patients with end-stage renal disease with and without diabetes mellitus. Perito Dial Bull 1985; 5: 241–247
- Ferrier T M. Comparative study of arterial disease in amputated lower limbs from diabetics and non-diabetics (with special reference to feet arteries). Med J Aust 1967; 1: 5–11
- Khodasevich L S, Osipov S M. Idiopathic arterial calcification: its link with calciphylaxis. Arkh Pathol 1990; 52: 23–29
- Selye H, Gobbiani G, Strebel R. Sensitization to calciphylaxis by endogenous parathyroid hormone. Endocrinology 1962; 71: 554–558
- Tochon-Danguy H J, Boivin G, Geoffrey G, Walzer C, Baud C A. Physical and chemical analysis of the mineral substance during the development of two experimental cutaneous calcifications in rats: topical calciphylaxis and topical calcergy. Z Naturforsch C 1983; 38: 135–140
- Boivin G, Walzer C, Baud C A. Ultrastructural study of the long-term development of two experimental cutaneous calcinoses (topical calciphylaxis and topical calcergy) in the rat. Cell Tissue Res 1987; 24: 68–71
- Mallick N P, Berlyne G M. Arterial calcification after vitamin-D therapy in hyperphosphatemic renal failure. Lancet 1968; 2: 13–16
- Krog M, Ejerblad S, Erkson I, Johnson H. Arterial calcification in uremic rats treated with 1-alphahydroxycholecalciferol and parathyroidectomy. Scand J Urol Nephrol 1984; 18: 227–239
- Miller S, Veron-Roberts E, McClure J. Cutaneous calciphylaxis reactions in the mouse and the rat and the effect of diphosphonates on the reaction in the rat. J Pathol 1984; 142: 7–13
- Rubinger D, Friedlander M M, Silver J, Kopolovic V, Czaczkes W J, Popovtzer M M. Progressive vascular calcification with necrosis of extremities in hemodialysis patients: a possible role of iron overload. Am J Kidney Dis 1986; 7: 125–129
- Kannel W B, McGee D L. Diabetes and cardiovascular risk factors: the Framingham study. Circulation 1979; 59: 8–13
- Seviour P W, Elkeles R S. High density lipoproteins and diabetic macrovascular disease. Diabetic Med 1985; 2: 348–351
- Parsy D, Dracon M, Gchera C. Lipoprotein abnormalities in chronic hemodialysis patients. Nephrol Dial Transplant 1988; 3: 51–56
- Bagdade J D, Albers J. Plasma high-density lipoprotein concentrations in chronic hemodialysis and renal transplant patients. N Engl J Med 1977; 296: 1435–1440
- Eascott H HG, Rose G A. Causes and mechanism of arterial disease. Vascular Surgery3rd ed., H HG Eascott. Churchill Livingstone. 1992; 1
- Heptinstall R H. End-stage renal disease. Pathology of the Kidney4th ed., R H Heptinstall. Little, Brown. 1992; 713